亞太地區結構心臟市場預測至 2028 年 - 區域分析 - 按產品、程序和最終用戶
市場調查報告書
商品編碼
1393997

亞太地區結構心臟市場預測至 2028 年 - 區域分析 - 按產品、程序和最終用戶

Asia Pacific Structural Heart Market Forecast to 2028 - Regional Analysis - by Product, Procedure, and End User

出版日期: | 出版商: The Insight Partners | 英文 142 Pages | 訂單完成後即時交付

價格

亞太心臟結構市場預計將從2022年的26.4967億美元成長到2028年的43.7455億美元。預計2022年至2028年CAGR為8.7%。

結構心臟器械領域的技術進步推動亞太結構心臟市場

與外科手術相比,經導管手術可以在更短的時間內改善患者的心臟狀況。此外,微創手術降低了手術和心肺風險,從而提高了患者滿意度。 TAVR因其能夠為退化性主動脈瓣狹窄的治療提供合理的選擇而受到越來越多的關注。 2017年,Edwards Lifesciences的Edwards Sapien閥門正在PARTNER試驗中進行研究。該瓣膜由牛心包組織瓣膜製成,並縫合在鈷鉻支架上。支架允許瓣膜最大程度地折疊,一旦擴張,就可以保持結構和徑向支撐。此外,結構性心臟裝置的最新發展重點關注左心耳(LAA)和卵圓孔未閉(PFO)封堵的適應症和結果,以預防心臟中風。提到了亞太心臟結構市場參與者的一些技術進步。 2023 年 2 月,美敦力宣布重新推出 Harmony 經導管肺動脈瓣 (TPV) 系統,這是一種微創替代心臟直視手術的方法,適用於患有天然或手術修復 RVOT 的先天性心臟病患者。 Evolut FX 在現有 Evolut 平台上添加了新功能,以增強醫生的易用性和可預測的瓣膜部署。 2022年5月,飛利浦推出了EchoNavigator 4.0,這是其影像導引治療解決方案的新版本,用於治療結構性心臟病。 EchoNavigator 4.0 為飛利浦 EPIQ CVXi 介入性心臟病學超音波系統的使用者提供了對該公司影像引導治療系統(稱為「Azurion 平台」)上的即時融合成像的控制。 2021 年 9 月,雅培的 Epic Plus 和 Epic Plus Supra 支架組織瓣膜獲得 FDA 批准,以改善主動脈瓣或二尖瓣疾病患者的治療選擇。透過這款新設備,雅培擴展了其 Epic 手術瓣膜平台。 2021 年 8 月,CORCYM 在現實環境中招募了第一位患者進行二尖瓣、主動脈和三尖瓣上市後研究,即 MANTRA。義大利萊切市醫院進行了首次植入,並採用了碳酸氫鹽主動脈機械瓣膜。 2021 年 8 月,第一個印度製造的 3D 列印心臟瓣膜在欽奈開發出來。新的心臟瓣膜是使用3D列印機開發的,可以克服人工心臟瓣膜的相關問題。因此,技術進步正在引領亞太結構心臟市場成長的新成長趨勢。

亞太結構心臟市場概況

亞太結構心臟市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。該地區在全球結構心臟市場中佔有重要的市場佔有率。由於老年人口大幅成長、心血管疾病日益嚴重以及該地區市場參與者推出創新產品等因素,預計亞太地區結構性心臟市場將在預測期內顯著成長。

亞太地區結構心臟市場收入及 2028 年預測(百萬美元)

亞太地區結構心臟市場細分

亞太地區結構心臟市場分為產品、程序、最終用戶和國家。

根據產品,亞太結構心臟市場分為封堵器、瓣環成形術環、心臟瓣膜球囊等。 2022 年,封堵器細分市場佔據亞太結構心臟市場的最大佔有率。

依手術方式,亞太結構性心臟市場分為心臟瓣膜狹窄、心臟瓣膜逆流和左心耳封堵術。 2022 年,心臟瓣膜狹窄細分市場在亞太結構性心臟市場中佔據最大佔有率。

根據最終用戶,亞太地區結構心臟市場分為醫院、門診手術中心等。 2022年,醫院細分市場在亞太結構心臟市場中佔據最大佔有率。

依國家/地區分類,亞太地區結構心臟市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年,中國主導亞太心臟結構市場。

雅培實驗室、美敦力公司、波士頓科學公司、Artivion Inc、Edwards Lifesciences Corp 和樂普醫療科技北京有限公司是亞太地區結構心臟市場的一些領先公司。

目錄

第 1 章:簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 亞太結構心臟市場 - 按產品
    • 亞太結構心臟市場 - 按程序
    • 亞太結構心臟市場 - 按最終用戶分類
    • 亞太地區結構心臟市場 - 按國家/地區

第 2 章:亞太地區結構心臟市場 - 要點

第 3 章:研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章:亞太地區心臟結構市場 - 市場格局

  • 概述
  • PEST分析
    • 亞太地區 PEST 分析
  • 專家意見

第 5 章:亞太地區結構心臟市場 - 主要市場動態

  • 市場促進因素
    • 創新結構性心臟服務的可用性
    • 心血管疾病病例和培訓計畫數量不斷增加
  • 主要市場限制
    • 程序成本高
    • 關於結構心臟裝置的嚴格規定
  • 主要市場機會
    • 人工智慧在結構性心臟的應用越來越廣泛
  • 未來的趨勢
    • 結構性心臟器械領域的技術進步
  • 影響分析

第 6 章:結構心臟市場 - 亞太地區分析

  • 亞太地區結構心臟市場收入預測與分析

第 7 章:亞太地區結構心臟市場 - 收入和 2028 年預測 - 按產品

  • 概述
  • 2021 年及 2028 年亞太地區結構心臟市場收入佔有率(按產品)(%)
  • 封堵器
  • 瓣環成形術環
  • 心臟瓣膜氣球
  • 其他

第 8 章:亞太地區結構心臟市場 - 2028 年收入和預測 - 按程序

  • 概述
  • 亞太地區結構心臟市場收入佔有率,按程序 2021 年和 2028 年 (%)
  • 心臟瓣膜狹窄
  • 心臟瓣膜逆流
  • 左心耳封堵術

第 9 章:亞太地區結構心臟市場 - 收入和 2028 年預測 - 按最終用戶

  • 概述
  • 2021 年及 2028 年亞太地區結構心臟市場收入佔有率(按最終用戶分類)(%)
  • 醫院
  • 門診手術中心
  • 心臟中心

第 10 章:亞太地區結構心臟市場 - 收入和 2028 年預測 - 國家分析

  • 亞太地區:亞太心臟結構市場
    • 概述
    • 亞太地區:亞太地區心臟結構市場,依國家分類,2021 年和 2028 年 (%)

第 11 章:亞太結構心臟市場 - 產業格局

  • 概述
  • 成長策略
    • 概述

第 12 章:公司簡介

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Artivion Inc
  • Edwards Lifesciences Corp
  • Micro Interventional Devices Inc

第 13 章:附錄

  • 關於洞察合作夥伴
  • 專業術語
Product Code: BMIRE00028939

The Asia Pacific structural heart market is expected to grow from US$ 2,649.67 million in 2022 to US$ 4,374.55 million by 2028. It is estimated to grow at a CAGR of 8.7% from 2022 to 2028.

Technological Advancements in the Field of Structural Heart Devices Fuel Asia Pacific Structural Heart Market

Transcatheter procedures lead to improvements in patients' heart conditions in shorter a period compared to surgical intervention. In addition, minimally invasive procedures have reduced surgical and cardiopulmonary risks, which results in increased patient satisfaction. TAVR has gathered more attention due to its ability to offer a reasonable option for the treatment of degenerative aortic stenosis. In 2017, the Edwards Lifesciences's Edwards Sapien valve was under the studies in the PARTNER trial. The valve has been made from a bovine pericardial tissue valve, and it is sutured on a cobalt-chromium stent scaffold. The stent allows the maximum possible folding of the valve, which allows to maintain the structural and radial support once it is expanded. Moreover, the recent developments in structural heart devices focus on indications, and results of left atrial appendage (LAA) and patent foramen ovale (PFO) closure to prevent cardioembolic stroke. A few of the technological advancements by the players in the Asia Pacific Structural Heart Market are mentioned. In February 2023, Medtronic announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired RVOT. Evolut FX added new features to the existing Evolut platform to enhance ease of use and predictable valve deployment for physicians. In May 2022, Philips launched EchoNavigator 4.0, the new release of its image-guided therapy solution, for the treatment of structural heart disease. EchoNavigator 4.0 provides the users of Philips' EPIQ CVXi interventional cardiology ultrasound system a control of live fusion-imaging on the company's Image Guided Therapy System called "Azurion - platform." In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform. In August 2021, CORCYM enrolled the first patient in the Mitral, Aortic, and Tricuspid Post-Market Study in a Real-World Setting, i.e., MANTRA. The first implantation was performed at Citta di Lecce Hospital in Italy with a Bicarbon aortic mechanical valve. In August 2021, the first Made in India 3D printed heart valve was developed in Chennai. The new heart valves were developed using 3D printers, which could overcome the problems related to artificial heart valves. Therefore, technological advancements are leading to new growth trends in the Asia Pacific Structural Heart Market growth.

Asia Pacific Structural Heart Market Overview

The Asia Pacific structural heart market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region holds a significant market share in the global structural heart market. The Asia Pacific structural heart market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, growing cardiovascular diseases, and launch of innovative products by market players in the region.

Asia Pacific Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Structural Heart Market Segmentation

The Asia Pacific structural heart market is segmented into product, procedure, end user, and country.

Based on product, the Asia Pacific structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on procedure, the Asia Pacific structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on end user, the Asia Pacific structural heart market is segmented into hospitals, ambulatory surgical centres, and others. The hospitals segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on country, the Asia Pacific structural heart market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific structural heart market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Lepu Medical Technology Beijing Co Ltd are some of the leading companies operating in the Asia Pacific structural heart market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific structural heart market.
  • Highlights key business priorities to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Structural Heart Market - by Product
    • 1.3.2 Asia Pacific Structural Heart Market - by Procedure
    • 1.3.3 Asia Pacific Structural Heart Market - by End User
    • 1.3.4 Asia Pacific Structural Heart Market - by Country

2. Asia Pacific Structural Heart Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Structural Heart Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis
  • 4.3 Expert's Opinion

5. Asia Pacific Structural Heart Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Availability of Innovative Structural Heart Services
    • 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Procedures
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements in the Field of Structural Heart Devices
  • 5.5 Impact analysis

6. Structural Heart Market -Asia Pacific Analysis

  • 6.1 Asia Pacific Structural Heart Market Revenue Forecast and Analysis

7. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Occluders
    • 7.3.1 Overview
    • 7.3.2 Occluders: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Annuloplasty Rings
    • 7.4.1 Overview
    • 7.4.2 Annuloplasty Rings: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Heart Valve Balloons
    • 7.5.1 Overview
    • 7.5.2 Heart Valve Balloons: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by Procedure

  • 8.1 Overview
  • 8.2 Asia Pacific Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • 8.3 Heart Valve Stenosis
    • 8.3.1 Overview
    • 8.3.2 Heart Valve Stenosis: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Heart Valve Regurgitation
    • 8.4.1 Overview
    • 8.4.2 Heart Valve Regurgitation: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Left Atrial Appendage Closure
    • 8.5.1 Overview
    • 8.5.2 Left Atrial Appendage Closure: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiac Centers
    • 9.5.1 Overview
    • 9.5.2 Cardiac Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 -Country Analysis

  • 10.1 Asia Pacific: Asia Pacific Structural Heart Market
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Asia Pacific Structural Heart Market, by Country, 2021 & 2028 (%)
      • 10.1.2.1 China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 China: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.1.4 China: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.4.1 China: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.4.2 China: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.5 China: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.2 Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Japan: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.2.4 Japan: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.4.1 Japan: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.4.2 Japan: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.5 Japan: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.3 India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 India: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.3.4 India: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.4.1 India: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.4.2 India: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.5 India: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.4 Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.3 Australia: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.4.4 Australia: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.4.1 Australia: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.4.2 Australia: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.5 Australia: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.5 South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.3 South Korea: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.5.4 South Korea: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.4.1 South Korea: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.4.2 South Korea: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.5 South Korea: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.6 Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.3 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.6.4 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.4.1 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.4.2 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.5 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)

11. Asia Pacific Structural Heart Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Artivion Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Micro Interventional Devices Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. China Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. China Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. China Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. China Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Japan Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Japan Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Japan Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. India Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. India Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. India Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. India Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. India Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Australia Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Australia Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Australia Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Australia Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Australia Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. South Korea Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. South Korea Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. South Korea Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. South Korea Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. South Korea Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Rest of Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Rest of Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Rest of Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Rest of Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Recent Organic Growth Strategies in Asia Pacific Structural Heart Market
  • Table 32. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Structural Heart Market Segmentation
  • Figure 2. Asia Pacific Structural Heart Market, by Country
  • Figure 3. Asia Pacific Structural Heart Market Overview
  • Figure 4. Occluders Segment Held Largest Share of Product Segment in Asia Pacific Structural Heart Market
  • Figure 5. Asia Pacific: PEST Analysis
  • Figure 6. Asia Pacific Structural Heart Market Experts' Opinion
  • Figure 7. Asia Pacific Structural Heart Market: Impact Analysis of Drivers and Restraints
  • Figure 8. Asia Pacific Structural Heart Market - Revenue Forecast and Analysis - 2019-2028
  • Figure 9. Asia Pacific Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 10. Occluders: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. Annuloplasty Rings: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Heart Valve Balloons: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Others: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Asia Pacific Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • Figure 15. Heart Valve Stenosis: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Heart Valve Regurgitation: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Left Atrial Appendage Closure: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • Figure 19. Hospitals: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Cardiac Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Asia Pacific Structural Heart Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 23. Asia Pacific: Asia Pacific Structural Heart Market, by Country, 2021 & 2028 (%)
  • Figure 24. China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)